Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Allograft rejection | R-HSA-9679028 | map05330 | Prestwick-864 | None | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | Prestwick-864 | None | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | Prestwick-864 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | Prestwick-864 | None | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | Prestwick-864 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | roxithromycin | 5906 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | roxithromycin | 5906 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | roxithromycin | 5906 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | roxithromycin | 5906 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | roxithromycin | 5906 | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | procyclidine | 4919 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | procyclidine | 4919 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | procyclidine | 4919 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | procyclidine | 4919 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | benzthiazide | 456255 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | benzthiazide | 456255 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | benzthiazide | 456255 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | benzthiazide | 456255 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | benzthiazide | 456255 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | benzthiazide | 456255 | drug-path |